Teladoc Health Names New Chief Legal Officer as Longtime Executive Exits

  • Adam Vandervoort, Teladoc Health’s Chief Legal Officer for 11 years, will resign effective November 1, 2026.
  • Jonathan Dorfman, currently Senior Vice President of Securities and Corporate Law, will succeed Vandervoort on November 2, 2026.
  • Dorfman joined Teladoc Health in 2020 through the Livongo acquisition and has led SEC reporting and corporate governance.
  • Vandervoort guided Teladoc through its IPO, pandemic growth, and regulatory changes during his tenure.

Teladoc Health’s leadership transition in its legal function comes at a time when the virtual care industry faces evolving regulatory landscapes and increasing scrutiny over corporate governance. The shift from a long-serving executive to an internal successor highlights the company’s focus on continuity and institutional knowledge. Dorfman’s background in SEC compliance and corporate governance suggests a strategic emphasis on maintaining robust regulatory compliance amid industry growth.

Governance Dynamics
How Dorfman’s promotion will impact Teladoc’s corporate governance and SEC compliance strategies.
Regulatory Headwinds
Whether Dorfman can sustain the regulatory adaptability demonstrated under Vandervoort’s leadership.
Execution Risk
The pace at which Dorfman integrates his experience from Livongo and prior roles into Teladoc’s legal framework.